Receptive substances proposed 1909 by Langley (nicotine)

Slides:



Advertisements
Similar presentations
LAKSHMAN KARALLIEDDE OCTOBER 2011
Advertisements

Kinetics: Reaction Order Reaction Order: the number of reactant molecules that need to come together to generate a product. A unimolecular S  P reaction.
Drug Chemistry and Toxicology CHE 618 Alexander Nazarenko.
DRUG-RECEPTOR INTERACTIONS
QUANTITATIVE ASPECTS OF DRUG ACTION
Cooperative Site Binding (11.8) Binding of ligands to a biomolecule can affect the ability of other active sites to bind ligands and is called cooperative.
Protein Structure/Function C483 Spring Proteins segments which fold first can promote the folding of other sections of the protein into the native.
Drug ? RESPONSE altering their biochemical &/or biophysical activity  Depress  Activate  Replace  Irritate  Destroy PHARMACODYNAMICS  Absorb 
Pharmacology-1 PHL 313 Second Lecture By Abdelkader Ashour, Ph.D. Phone:
Chp 2 Molecules and Cells in Animal Physiology Read Chp 2 of the book Use the notes for Human Physiology We will see metabolism and the enzymes in more.
Pharmacology-1 PHL 313 Fourth Lecture By Abdelkader Ashour, Ph.D. Phone:
Receptors and Drug Action Receptors: Specific areas of cell membranes (proteins, glycoproteins)* When bound to ligand, positive or negative biological.
Principles of Pharmacology: Pharmacodynamics
Receptor and Signal Transduction Receptor Concept Dept. Pharmacology, Tzu Chi Univ. T.H. Chiu I. References for the lecture II. Development of receptor.
Presentation Schedule. Homework 8 Compare the tumor-immune model using Von Bertalanffy growth to the one presented in class using a qualitative analysis…
Principles of Pharmacology: Pharmacodynamics
Quantifying the drug-target binding affinity. Receptors as targets (Receptors are 45% of current drug targets) Receptors are areas of proteins found in.
Section 1, Lecture 7 Pharmacodynamics
BASIC PHARMACOLOGY 2 SAMUEL AGUAZIM(MD).
RESPONSE altering their biochemical &/or biophysical activity  Depress  Activate  Replace  Irritate  Destroy PHARMACODYNAMICS  Absorb  Distribute.
HuBio 543 September 6, 2007 Frank F. Vincenzi
A protein binds a ligand through a specific, reversible interaction
How drugs Act :General principles Lecture 2
Year One Pharmacodynamics
PHARMACODYNAMICS M.T. Piascik PHA 824 November 11, 2008.
Dr. Laila M. Matalqah Ph.D. Pharmacology Pharmacodynamics 1 General Pharmacology M212.
Intracellular Signal Transduction Pathways and Cascades.
Receptor Theory & Toxicant-Receptor Interactions Richard B. Mailman.
Dr. Laila M. Matalqah Ph.D. Pharmacology Pharmacodynamics 2 General Pharmacology M212.
Clinical Pharmacokinetics. Time course Duration Onset Absorptive phase Elimination phase.
Title: Lesson 4 B.2 Enzymes Learning Objectives: – Describe the structure and the function of an enzyme – Identify and explain the factors that affect.
How Do Drugs Affect Synapses? BY RUI XIAO. Psychoactive Drugs  Psychoactive drugs are chemical substances that can alter brain functions and result in.
Modelling biochemical reactions using the law of mass action; chemical kinetics Basic reference: Keener and Sneyd, Mathematical Physiology.
DRUG RECEPTORS AND PHARMACODYNAMICS
Pharmacodynamics What the drug does to the body?
Pharmacodynamics. * The study of the biochemical and physiologic effects of drugs and the molecular mechanisms by which those effects are produced * The.
Pharmacokienetic Principles (2): Distribution of Drugs
Receptors and Drug Action
Toxicology Drug Poisioning.
Affinity and Avidity by: Omar Ammar
Receptor Theory & Toxicant-Receptor Interactions
MBBS-BDS LECTURE NOTES
PHL 210 Pharmacology Second Lecture By Abdelkader Ashour, Ph.D. Phone:
Understanding the Basics of Pharmacology
Drug-Receptor Binding and Receptor Types
Toxicology Drug Poisioning.
Chapter 6 CHM 341 Fall 2016 Suroviec.
Drug-Receptor Interactions
INTRODUCTION to Pharmacology
Endocrinology Endocrinology is concerned with the study of the biosynthesis, storage, chemistry, and physiological function of hormones and with the cells.
Pharmacodynamics 2.
RECEPTORS:STRUCTURAL & FUNCTIONAL FAMILIES OF RECEPTOR PRESENTED BY: KULKARNI AMOUGH ANIL M. Pharm (1 st year) Department of Pharmacology. KLES College.
Principles of pharmacodynamics
Receptors & Drug action at Receptors
بسم الله الرحمن الرحيم.
Pharmacology UG-Course
Drug-Receptor Interactions
RECEPTOR “ A receptor is a macromolecular component of a cell or organism that interacts with a drug and initiates the chain of biochemical events leading.
Pharmacodynamic Dr. Hashem Mansour.
Introduction to Pharmacology
Lee E Limbird, Palmer Taylor  Cell 
Efficacy, Potency and Safety of Drugs
IMMUNOASSAYS Basic Concepts & Definitions
2.5 - Enzymes.
Introduction to Pharmacology
Drug-Receptor Interactions and Pharmacodynamics (cont.)
Plot of BOUND against FREE ligand
Enzyme Control of Metabolism
Drug- Receptor Interaction
Full agonists The “agonists” referred to so far are FULL AGONISTS
Presentation transcript:

Receptive substances proposed 1909 by Langley (nicotine) Receptive substances proposed 1909 by Langley (nicotine). Before definitive demonstration of chemical transmission 1921 (Loewi). Two main classes of receptor; ionotropic and metabotropic mediate fast and slow transmission, respectively. All these found in the plasma membrane (steroid hormone receptors are intracellular, nuclear).

Ionotropic vs metabotropic/ overview

What are the criteria for a receptor? Capacity to bind a ligand (not unique) Membrane associated; induce biological response when bound (not unique) Do not change the ligand by binding (not unique) True neurotransmitter receptors do all the above and mediate the response to the transmitter. Knock out receptor get no response

Radioligand binding assay Tissue homogenate High activity radioactive labeled ligand Unlabeled ligand Total binding measured in the presence of increasing concentrations of labeled ligand Non-specific binding measured as above but in the presence of excess unlabeled (cold) ligand Specific binding is the subtraction of the two 1971. Overcome difficulty of making in vivo measures of receptor binding—drugs cross BBB, hydrophobicity of ligand may restrict access to some membranes, metabolism of drug before reaching receptor, compensatory changes may take place rapidly in the prolonged presence of the drug.

Criteria defined by radioactive binding assays: A Specific Receptor Saturability Very small amount of receptor in tissue Specific and high affinity Found in biologically relevant sites High receptor occupancy with low, physiologic concentrations of ligand Biologic relevance Distribution of receptor matches distribution of ligand Binding or displacement of drugs should correlate with the potency of those drugs Reversibility Timing and recovery of ligand unchanged Become the criteria used today

Saturation binding Saturability and specificity. Specific=low capacity, high affinity

Binding characteristics Bmax: density of receptors kD: 1/affinity of receptor for the ligand Binding according to law of mass action [L] + [R] [LR] Rate of reaction proportional to [ ] reactants K1=[L]*[R] K2=[LR] At equilibrium, k1=k2. Substituting, k1/k2=[L]*[R]/[LR]=kD, the equilibrium dissociation constant kD is equal to the concentration of ligand that produces 50% of maximal binding

Saturation binding curves QNB is an antagonist at the muscarinic acetylcholine receptor. Chemical warfare agent. Specific binding in different tissues. Point of plateau is Bmax; read concentration off Y axis. kD is the concentration of ligand required to reach half maximal binding.

Scatchard Transformation Not always easy to read Bmax and kD from a saturation plot. Plot bound/free vs bound (pmol/mg protein). Bmax is the x-intercept, kD is 1/slope. Steeper slope=higher affinity

Comparing slopes reveals that affinity does not change—probably the same receptor. But different x-intercepts, means different amounts of the receptor in different tissues

Displacement or indirect binding Displacement binding. At 50% displacement, concentration of inhibitor is the IC50. Related to ki formally, but usually we can assume IC50=ki. Displacement binding tells you whether two substances interact with (bind) the same receptor.

IC50 vs. Potency of different DA receptor antagonists Biologic potency of drugs that treat schizophrenia correlates with their ability to displace the dopamine receptor ligand haloperidol but not SCH-23390. Tells something about where effective drugs probably act, and therefore what may be wrong with dopamine transmission in schizophrenia.

Muscle relaxants and their ability to displace diazepam (valium) Correlation between the muscle relaxing properties of various drugs and their ability to displace diazepam (aka valium). Note that the best you can do is get a good correlation. Binding in vitro can not tell you about drug actions.

Hill Plot The slope is 1 when the receptor occupancy exactly corresponds to the number of binding sites. The response is equal to the amount of receptor bound. i.e. one binding site per receptor. Ex. Naloxone, an opioid antagonist.

Hill Plot-Cooperativity When the slope is not =1 or the line is not straight, it indicates cooperativity. Ie. There are multiple binding sites and the binding of one molecule influences the binding at other sites. These are allosteric influences. Not all allosteric interactions have to be the same molecule binding. Hemoglobin-4 O2 binding sites. First 02 bound makes subsequent affinity for O2 higher. CO, cyanide, NO and other toxic gasses can bind this site with higher affinity than O2, leading to death.

Some problems with radioligand binding data: Maximal response can be achieved with only a portion of receptors bound Spare receptors Agents that bind equally may yield different biological response Full agonist, partial agonist, antagonist Efficacy or intrinsic activity Desensitization: decreased response with continuous exposure to drug (binding unchanged)

Explain: Caveats of radioligand binding assays in homogenized tissue…binding does not always correlated with levels of mRNA or protein. What else could affect binding?

Receptor localization Receptors must be found at post-synaptic density/membrane Complex systems of scaffolding molecules are in place to hold receptors at the right location Link receptors to downstream signaling pathways too

Receptor localization to plasma membrane—lipid rafts Receptor localization to plasma membrane—lipid rafts?—is a major determinant of binding capacity as well as signaling capacity. Scaffolding proteins serve to anchor receptors at the membrane as well as recruit and stabilize key downstream signaling molecules.

Best studied in glutamate receptors and learning and memory.